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An obese 22-year-old man with a history of recurrent
respiratory infections presented to the emergency room
with left pleuritic chest pain, productive cough with
mucupurulent sputum and an axillary temperature of
37.7°C. Blood work showed elevated inflammatory
parameters and chest X-ray was relevant for
heterogeneous infiltration in the left base and opacity of
the left costophrenic angle. An angio-CT scan revealed
areas of bilateral consolidation with presence of an
arterial branch originating from the aorta to the
collected area of the left lower lobe, consistent with a
respiratory infection grafted on a intralobar pulmonary
sequestration of the left lung base. The infectious
process was treated and the patient was planned for
a lower left lobectomy.
BACKGROUND
In 1777, Hubber described an anomalous artery
that originates in the aorta and supplies a normal
lower lung lobe.1 In 1861, Rokitansky and
Rektorzik described a series of cases that resembled
what is now known as extralobar pulmonary
sequestration (EPS).1 Pryce, in 1946, introduced
the term, PS, and defined all its anatomy.1 2
PS is a rare congenital malformation of the lower
respiratory tract, responsible for 0.15–6.4% of all
congenital lung malformations. It consists of an
area of pulmonary tissue that does not usually com-
municate with the tracheobronchial tree, and
receives its blood supply from the systemic circula-
tion, typically from an accessory vessel originating
on the thoracic or abdominal aorta.1
From an anatomical point of view, the PS is clas-
sified into two types: intralobar PS (IPS), where the
abnormal lung mass is located within a normal
lung lobe and is not coated with a proper visceral
pleura; and EPS, where the mass of abnormal lung
is separated from the rest of the normal paren-
chyma by proper visceral pleural coating. IPS is
more common than EPS, corresponding to about
75–90% of all PS, probably due to the patho-
physiological mechanisms involved in the develop-
ment of each.
We present a case of a young man admitted to
the hospital because of community-acquired pneu-
monia (CAP) and whose clinical research path led
to a diagnosis of IPS with institution of appropriate
therapy.
CASE PRESENTATION
A 22-year-old man with a history of pulmonary
infections, a non-smoker taking no chronic
medication, was admitted to our emergency depart-
ment for the second time in 2 weeks, for a pleuritic
pain of the left hemithorax and progressively wor-
sening productive cough and asthenia. He denied
dyspnoea and had no other symptoms.
On pulmonary auscultation, a vesicular murmur
was present and symmetric, crackles were present
on the left pulmonary base. He was tachycardic
(100 bpm). Blood tests showed a C reactive protein
of 270 mg/L and a leucocyte count of 179 000/μL.
Blood gas analysis breathing room air was normal.
Chest X-ray showed heterogeneous infiltrates in the
left pulmonary base, with opacity of the left costo-
phrenic angle (figure 1).
Given the clinical presentation and laboratory
tests results, the patient was admitted for CAP to
monitor therapy response in a twice presenting
young patient.
Blood and sputum cultures were made and
empirical antibiotic therapy with ceftriaxone and
clarithromycin was started.
On the second day of hospitalisation, the
patient’s status worsened, with new-onset dyspnoea
and hypoxaemia on breathing room air.
INVESTIGATIONS
An angio-CT scan was ordered to exclude pulmon-
ary thromboembolism (PTE), which was considered
given the sudden appearance of the symptoms. The
CT revealed: ‘Consolidation of the lower lobes,
especially on the left. In the lower left lobe, the
consolidation area had associated cystic bronchiec-
tasis, and adjacent to this, particularly in the basal
segments, there was a fluid density area with mul-
tiple dispersed gas bubbles not communicating,
Figure 1 Motley infiltrate in the left base, with
obliteration of the costophrenic left angle.
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suggesting thick liquid/collected. An arterial branch originating
from the aorta (thoracic-abdominal transition) coexisted, and
was directed to the epicentre of the aforementioned net area,
suggesting a probable respiratory infection grafted on a pulmon-
ary left lung base sequestration, without clear images of PTE’
(figure 2).
TREATMENT
Antibiotics were switched to meropenem and vancomycin due
to the clinical deterioration.
On the third day after admission the patient, already on
broad-spectrum antibiotics, develops an episode of severe dys-
pnoea and hypoxaemia, requiring a high-concentration oxygen
mask, and was transferred to an intermediate care unit for
increased surveillance and monitoring. A day later, after being
clinically stabilised, the patient returned to the internal medicine
department.
OUTCOME AND FOLLOW-UP
Progressive clinical and analytical improvement was achieved,
and on the eighth day of hospitalisation, oxygen therapy was no
longer needed. The patient completed 14 days of antibiotic
therapy with meropenem and vancomycin, and a control
angio-CT scan revealed ‘significant improvement in imaging,
with resolution of almost all the consolidated parenchyma in
the left lower lobe. Within the left lower lobe, cystic bronchiec-
tasis was identified’ (figure 3).
Plethysmography and bronchoscopy were requested and
revealed no changes, with normal bronchoalveolar lavage liquid
analysis.
The patient was discharged on the 18th day, completely
asymptomatic, and was directed to a cardiothoracic surgery out-
patient appointment to undergo lower lobectomy and mainten-
ance of respiratory kinesiotherapy.
DISCUSSION
PS is a rare lung disease that can occur as one of two possible
variants: extralobar and intralobar, with the latter being three
times more frequent.1 The intralobar form has a similar distri-
bution between genders and is usually diagnosed after 20 years;
it is a result of acute pneumonia, most often in the third decade
of life.2–5
Regarding its physiopathology, the embryological basis for the
development of PS and other congenital malformations of the
lower respiratory tract is not yet fully understood.6 7 It is
known, however, that changes can occur at a very early stage of
embryonic development, even before the separation of aortic
and pulmonary circulations.8 One possibility, supported by
several studies, is the fact that all defects involving embryonic
lung buttons represent a spectrum of the same embryological
defect.8–10
Typically, PS is revealed after an acute respiratory infection or
after cardiac symptoms.1 Dyspnoea, cyanosis, haemoptysis and
respiratory failure are often found in these patients,1 and the
vast majority have a history of repeated respiratory infections in
childhood, which is not required to establish the diagnosis.11 If
present, cardiac symptoms are due to a left–right shunt and are
directly related to the volume of blood flow, which in turn is
dependent on the vessel’s calibre anomaly.12
Chest roentgenogram is one of the fulcral examinations for
the diagnosis of PS, requiring confirmation by arteriography and
CT scan.2 11 In the chest X-ray, PS usually appears as a radio-
opaque image or parenchymal area with diffuse density. The
safest diagnostic preoperative approach is arteriography, which
has the ability to show the anomalous systemic artery that sup-
plies the lesion.13 CT scan has been used to demonstrate abnor-
mal parenchymal characteristics, but it may also identify
aberrant blood supply sequestration in the lung.11 Preoperative
angiography not only confirms the diagnosis, but also shows the
origin of the blood supply, crucial to the success of the
intervention.
Treatment of PS consists of surgical resection of the seques-
tered lung parenchyma. This intervention is usually a simpler
variant in extralobar type, since the malformation is well demar-
cated from normal lung by the visceral pleura.14 In the case of
an intralobar embodiment, the inflammatory changes resulting
from previous infections may complicate the procedure and, in
some cases, destroy the intersegment plane. Therefore, lobec-
tomy resection of the sequestered segment is often the treatment
of choice.14–16 There are few postoperative complications of the
procedure, which substantially improves the quality of life of
these patients.11
The histopathological examination of the lung tissue with PS
typically reveals a cystic or solid mass containing normal lung
constituents, such as smooth muscle, bronchial epithelium and
cartilage, but with the absence of bronchial structure and, in
Figure 2 Pneumonic bilateral process, with areas of water density
and non-communicating gas bubbles. Arterial branch originating from
the aorta that leads to the area of collection, highlighting the
intralobar pulmonary sequestration.
Figure 3 Almost complete resolution of the left consolidated
parenchyma. Left lower lobe cystic bronchiectasis.
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most cases, no communication with the lung tissue. As noted by
Halkic et al3 and Louie et al,12 the long-term evolution of surgi-
cal patients is excellent, confirming the highly positive results of
surgical treatment of PS.13
In the case presented, the fact that the first therapeutic treat-
ment was not accompanied by clinical improvement, motivated
admittance to the emergency room (ER), and may be justified
due to the structural changes resulting from the congenital mal-
formation, which favoured occurrence of infections by
antibiotic-resistant microorganisms.
So, when the patient re-presented to the ER, with continuing
symptoms and the absence of clinical improvement, an anti-
biotic regimen recommended for CAP, namely, a combination of
amoxicillin/clavulanic acid with clarithromycin, was instituted.
The second episode of respiratory decompensation was prob-
ably due to the fact that, once again, the predisposition to infec-
tions associated with sequestration area favoured the growth of
microorganisms with increased resistance, so the current anti-
biotic therapy would be insufficient for the aetiological agent
responsible for the symptoms. For this reason, and with a wor-
sening clinical condition in a young patient with no other risk
factors to justify decompensation, broad-spectrum antibiotic
therapy with meropenem and vancomycin was immediately
initiated.
At the time of clinical decompensation that motivated transfer
to the intermediate care unit, and with the angio-CT allowing
better characterisation of vascular and lung parenchyma, exclu-
sion of a PTE was also achieved, since the patient’s young age
did not favour thrombosis prophylaxis; however, since the
patient was overweight and was mostly immobilised in bed
during hospitalisation, this was also a possibility that had to be
considered as a potential cause of decompensation.
It is important to highlight that a bronchoscopy was per-
formed at an advanced stage of admission, given the consensus
of the medical and pneumology team not to perform invasive
tests (such as a bronchoscopy) while there was no sustained clin-
ical stability. Therefore, its realisation coincided with the final
phase of the broad-spectrum antibiotic treatment cycle, with the
infection being virtually resolved. That is possibly the reason
why the bronchoalveolar lavage revealed no changes.
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Learning points
Intralobar pulmonary sequestration is a malformation that
predisposes to recurrent respiratory infections. It is difficult to
diagnose unless a more comprehensive directed investigation (to
the vasculature and pulmonary parenchyma) is undertaken.
Early diagnosis is of paramount importance to prevent recurrent
respiratory infections, which are often refractory to treatment
with antibiotics. CT scan and angiography are the preferred
tests for a safe and definitive diagnosis. The classical treatment
involves surgical intervention, with full quality of life recovery
only a short time after surgery.
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